The spinal cord injury treatment market is witnessing robust growth, propelled by increasing incidence rates and groundbreaking advances in neural regeneration technologies. Novel therapeutic approaches including stem cell therapy, neurostimulation devices, and axon regeneration biologics are creating new treatment paradigms. Industry innovators such as Lineage Cell Therapeutics, ReNetX Bio, and NervGen Pharma are at the forefront of developing potentially transformative therapies for SCI patients worldwide.
Download the Latest Market Insights:
https://www.delveinsight.com/infographics/spinal-cord-injury-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr